Hassan Aliashrafzadeh

I graduated from Tabriz University, School of Medical Sciences, in 2020, as a physician. I was interested in the neurology field so I worked on neurology subjects (traumatic brain injury) in my thesis in 2020. Also, I have over three years of experience in Iran's Health and Treatment and Research Centers, and I am honored for my performance during the COVID-19 pandemic in the treatment of patients. I have co-authored the publication of 4 technical papers on Traumatic Brain Injuries, Cancer, Antitumor agents, and COVID-19 (cited below). Since Neurological disease side effects are one of the most common causes of disability and Loss of quality of life, I am very much interested in continuing clinical and laboratory research in the field of Neurology to improve the quality of life and health of patients. I believe, my presence in pioneering scientific groups can increase my scientific communication and networking which will be very important for my future career.

• Traumatic Brain Injuries (TBI)
• Acute Ischemic Stroke
• Seizure
• Electroencephalogram (EEG)
• Glioblastoma multiforme and CNS cancers
• Alzheimer's disease
• Hypoxic-ischemic disease
• Resveratrol and Nobiletin
• Antitumor agent
• Drug resistance
• Public Health Emergencies
• Covid 19

• UC Davis Rodent Survival Surgery, University of California-Davis, 06/2024
• Animal Care and Use 101, University of California-Davis, 06/2024
• Laboratory Techniques including PCR, Western Blot, Cell Culture, and Flow Cytometry, Iran University of Medical Sciences, 07/2022
• Research training workshop, Manbe Pars Pajoheh Institute, 04/2021
• Research in medical science, Summer School in Education Development Center of Shiraz University of Medical Sciences, 09/2021

• I was recognized and appreciated as a medical doctor for Saving the lives of pregnant women at Kesharavaz Health Center in the City of Shahindezh, West Azerbaijan Province, Iran. March,2021
• I was recognized and appreciated for my efforts and hard work in saving lives during the Corona pandemic in the same Medical facilities in 2021.

• Journal of Frontiers in Pharmacology

• Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths, Karkon-Shayan S, Aliashrafzadeh H, Dianat-Moghadam H, Rastegar-Pouyani N, Majidi M, Zarei M, Bahramvand Y, Babaniamansour S, Jafarzadeh E, Acta Histochemica, 08/01/2023
• Nobiletin in cancer therapy; mechanisms and therapy perspectives, Moazamiyanfar R, Rezaei S, Aliashrafzadeh H, Rastegar-Pouyani N, Jafarzadeh E, Mouludi K, et al., Curr Pharm Des, 04/26/2023, https://www.eurekaselect.com/216193/article
• Human Responses in Public Health Emergencies for Infectious Disease Control: An Overview of Controlled Topologies for Biomedical Applications, Naseri K, Aliashrafzadeh H, Otadi M, Ebrahimzadeh F, Badfar H, Alipourfard I, Contrast Media & Molecular Imaging, 09/01/2022
• Comparison of the Outcome of Altplas Administration after Acute Ischemic Stroke in Patients Over 80 Years and Under 80 Years Admitted, Shayan SK, Aliashrafzadeh H, Rezayitalab F, Sobhani M, Zarei M, Journal of Pharmaceutical Negative Results, 09/22/2022